Aveanna Healthcare Holdings Inc AVAH.OQ AVAH.O is expected to show a rise in quarterly revenue when it reports results on August 7 for the period ending June 30 2025
The Atlanta Georgia-based company is expected to report a 6.0% increase in revenue to $535.367 million from $504.96 million a year ago, according to the mean estimate from 8 analysts, based on LSEG data.
LSEG's mean analyst estimate for Aveanna Healthcare Holdings Inc is for earnings of 3 cents per share.
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 2 "strong buy" or "buy," 5 "hold" and 2 "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Aveanna Healthcare Holdings Inc is $5.75, about 33.6% above its last closing price of $3.82
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Mar. 31 2025
0.00
0.00
0.10
Beat
7,093
Dec. 31 2025
0.00
0.00
0.05
Beat
2,100
Sep. 30 2024
-0.01
-0.01
0.02
Beat
260
Jun. 30 2024
-0.01
-0.02
0.01
Beat
150
Mar. 31 2024
-0.05
-0.05
-0.03
Beat
36.8
Dec. 31 2023
-0.02
-0.02
-0.02
Met
15.8
Sep. 30 2023
-0.03
-0.03
-0.03
Met
-12.5
Jun. 30 2023
-0.04
-0.04
-0.02
Beat
44.8
This summary was machine generated August 5 at 13:18 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)